ArticleHuman molecular genetics2020

Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes.

Gretl Hendrickx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.